Michael Bonney

Michael Bonney

Net worth: 6 M $ as of 30/05/2026

67 year
Health Technology
Commercial Services
Miscellaneous

Profile

Michael W. Bonney is a businessperson who has been at the helm of 7 different companies. He occupies the position of Chairman at Alnylam Pharmaceuticals, Inc., Chairman for Kaleido Biosciences, Inc. and Chairman for Magenta Therapeutics, Inc. He is also on the board of Bristol Myers Squibb Co., Life Sciences Cares and X-Biotix Therapeutics, Inc. and Chairman of Bates College. In the past he held the position of Chairman of Rare LLC (Virginia), Director-National Business at Zeneca Pharmaceuticals, Partner at Third Rock Ventures LLC, Vice President-Sales & Marketing at Biogen, Inc., Director at Cubist Pharmaceuticals LLC, Chairman of Gulf of Maine Research Institute and Director at Biotechnology Innovation Organization. Mr. Bonney received an undergraduate degree from Bates College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/08/2025 20,804 ( 0.02% ) 6 M $ 30/05/2026
17/03/2026 0 ( -.--% ) - $ 30/05/2026

Michael Bonney active positions

CompaniesPositionStart
AUTOLUS THERAPEUTICS PLC Chairman 31/03/2024
IMMUNIC, INC. Chairman 15/05/2026
Director/Board Member -
Director/Board Member 20/04/2020
Director/Board Member -
Chairman 08/01/2023
Director/Board Member -

Former positions of Michael Bonney

CompaniesPositionEnd
ALNYLAM PHARMACEUTICALS, INC. Chairman 04/01/2023
KALEIDO BIOSCIENCES, INC. Chief Executive Officer 20/08/2018
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Michael Bonney's experience

Training of Michael Bonney

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

69

1st degree connections

34

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Miscellaneous

Miscellaneous

Miscellaneous

Miscellaneous

Finance

Health Technology

Consumer Services

Commercial Services

Health Services

Health Technology

Health Technology

Finance

Commercial Services

Pharmaceutical Manufacturers Association of America

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Bonney